Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms

Through five years following initial implantation in an FDA-approved study, the Talent Abdominal Stent Graft from Medtronic, Inc., demonstrated durable safety and effectiveness in patients with abdominal aortic aneurysms.

SonoSite Announces Plans to Acquire Cardiovascular Disease Management Company, CardioDynamics

SonoSite, Inc., the world leader and specialist in hand-carried and point-of-care ultrasound, today announced that it has reached an agreement to acquire CardioDynamics International Corporation.

Next-Generation Mechanical Heart Pump Implanted In Heart Patients

Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System.

Endograft Introduction System Enhances Control During Thoracic Aortic Aneurysm Treatment

Physicians will now experience a new level of control while placing endografts during thoracic endovascular repair procedures, with the launch of Cook Medical’s new Z-TRAK PLUS™ Introduction System.

Covidien Launches Alarm Management System For The Nellcor™ OxiMax™ N-600x™ Pulse Oximeter

Covidien, a leading global supplier of healthcare products, today announced the global launch of its Alarm Management System for the Nellcor™ OxiMax™ N-600x™ pulse oximeter.

Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT™ Falcon At EuroPCR

Invatec, a comprehensive innovator of interventional products, today announced the availability of its newly CE marked coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.

Medtronic’s CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach

Medtronic, Inc. announced new data presented today on the safety and effectiveness of Medtronic’s CoreValve system via a novel, subclavian approach.

Direct Flow Medical Completes First Human Use of 18F Percutaneous Aortic Valve System

Direct Flow Medical, Inc. a privately held, emerging medical device Company developing a next generation, minimally invasive implant to treat patients with heart valve disease announced today the first human use of their new 18 French Percutaneous Aortic Valve (PAV) System.

Most read

Latest

^